Fast-acting ketamine by-product – may be future therapy for Alzheimer’s, Parkinson’s
There is new hope for people suffering from depression. Researchers have identified a compound, hydroxynorketamine (HNK), that may treat symptoms of depression just as effectively and rapidly as ketamine, without the unwanted side effects associated with the psychoactive drug, according to a study in the July issue of Anesthesiology, the official medical journal of the American Society of Anesthesiologists® (ASA®). Interestingly, use of HNK may also serve as a future therapeutic approach for treating neurodegenerative disorders such as Alzheimer’s and Parkinson’s diseases, the authors note.
“The clinical use of ketamine therapy for depression is limited because the drug is administered intravenously and may produce adverse effects such as hallucinations and sedation to the point of anesthesia,” said Irving Wainer, Ph.D., senior investigator with the Intramural Research Program at the National Institute on Aging, Baltimore. “We found that the HNK compound significantly contributes to the anti-depressive effects of ketamine in animals, but doesn’t produce the sedation or anesthesia, which makes HNK an attractive alternative as an antidepressant in humans.”
Read more . . .
The Latest on: Depression
[google_news title=”” keyword=”Depression” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Depression
- Stress and depression linked to air pollution could impact heart healthon May 8, 2024 at 5:00 pm
A study has revealed the dual threat posed by air pollution – depression and stress along with cardiovascular disease linked to poor mental health. Researchers looked at data from more than 3,000 ...
- Marlon Wayans Speaks Honestly about His Depressionon May 8, 2024 at 2:00 pm
Whether you know it or not, May is Mental Health Awareness Month and in a new interview actor and comedian Marlon Wayans is opening up about his struggles.
- New guidelines for depression care emphasize patient-centered approach in Canadaon May 8, 2024 at 1:33 pm
Psychiatrists and mental health professionals have a new standard for managing major depression, thanks to refreshed clinical guidelines published today by the Canadian Network for Mood and Anxiety ...
- Ketamine Noninferior to ECT for Outpatients With Major Depressionon May 8, 2024 at 12:44 pm
NEW YORK CITY -- Treatment with ketamine was noninferior to electroconvulsive therapy (ECT) for major depressive disorder, two meta-analyses showed, though it was inferior for patients hospitalized ...
- Psychedelic Toad Venom Shows Promise for New Depression Treatmenton May 8, 2024 at 12:00 pm
Scientists have mapped the structure of a psychedelic drug derived from the Colorado River toad, which seems to have antidepressant effects.
- Serotonergic neuron findings suggest possible treatment for depression-related infertilityon May 8, 2024 at 11:12 am
Their findings also provide an explanation and possible treatment for the decreased fertility observed in people with depression. The results were published in Scientific Reports. People who lack ...
- New device that emits magnetic field may offer hope for treating depressionon May 8, 2024 at 9:38 am
A head-mounted device that generates an ultra-low frequency ultra-low magnetic field has been found to improve the symptoms of four male patients diagnosed with major depressive disorder. Future ...
- Psychedelic Toad Venom Could Be Used To Treat Depression Based On New Evidenceon May 8, 2024 at 9:36 am
Modern science has dreamed up a wide variety of treatments for depression, anxiety, and other mental issues, and researchers may have stumbled across a ...
- Psychedelic toxins from toads could treat depression and anxietyon May 8, 2024 at 8:00 am
By Corryn WetzelA psychedelic compound secreted by a poisonous toad could help treat depression and anxiety, according to a study in mice.When frightened, Colorado river toads (Incilius alvarius) ...
- New guidelines for depression care emphasize patient-centred approachon May 7, 2024 at 5:00 pm
Psychiatrists and mental health professionals have a new standard for managing major depression, thanks to refreshed clinical guidelines. Psychiatrists and mental health professionals have a new ...
via Bing News
